About Dr Alok Sharma
Born: Alok Kundanlal Sharma, June 27, 1961 (age 57) India.
Dr Alok Sharma’s Education:
Dr Alok Sharma has done his MS (Gen Surgery), M.Ch (Neurosurgery). Dr Alok Sharma has done a Fellowship in Stereotactic and Functional Neurosurgery and Gamma Knife Therapy. He has done a Fellowship in Stereotactic and Functional Neurosurgery and a Fellowship in Neurotransplantation
Nationality: Dr Alok Sharma is an Indian
Dr Alok Sharma is an alumnus of prestigious and reputed Seth G.S. Medical College and KEM Hospital of Mumbai University. He has been a part of the “Leksell Gamma Knife training course “held at the Karolinska Hospital in Stockholm, Sweden. He has done a Fellowship at the University of Colorado Health Sciences Center in Denver, USA University Clinic Freiburg. he has had training in “Stereotactic and Functional Neurosurgery from the Nihon University, Tokyo, Japan. Dr Sharma has had training in Neuroembrology and Cranial Base surgery from Osaka City University Hospital, Osaka, Japan. He has attended training at the MCP Hahnemann University, Pittsburgh, USA, “Neuroendoscopy” at the Department of Neuroendoscopy Allegheny General Hospital, Pittsburg, USA, and Microsurgery by participation in a “5 day course in microsurgery” at the Laboratory of Microsurgery, Department of Neurosurgery University Hospital Zurich, Switzerland, and training at the W.M. Keck Center for Collaborative Neurosciences State University of New Jersey.
Medical Career As a Neurosurgeon and Neuroscientist
Institutions: Dr Alok Sharma is the Director of NeuroGen Brain and Spine Institute in Mumbai, India and the Professor and Head of Department of Neurosurgery at LTMG hospital and LTM Medical College LTMG Hospital, Sion, Mumbai. He is also a Consultant Neurosurgeon at Fortis Hospital, Mumbai.
Dr Sharma has pioneered the research and clinical application of Cell therapy for Incurable Neurological Conditions. His work has resulted in opening up of treatment options for conditions such as Autism, Cerebral Palsy, Muscular Dystrophy, Spinal Cord Injury, Stroke, etc for which earlier there were no definitive treatments. So far, he has treated over 8000 patients with Cell therapy for these conditions.
Dr Sharma obtained his MBBS, M.S. and M.Ch. from the Seth G.S. Medical College and KEM Hospital of Mumbai University. Subsequently, he did fellowships in two departments which were the first to perform neural transplantations. In 1995, he did his Fellowship in Stereotactic and Functional Neurosurgery and Gamma Knife Therapy at the Karolinska hospital in Stockholm, Sweden, where neural transplantation was done for the first time ever in the world and in 1998, he also did his Fellowship in Neurotransplantation at the University of Colorado Health Sciences Center in Denver, USA where the world's first randomized trial on cell transplantation for Parkinson's was done. Dr Alok also did brief trainings at the National Hospital for Neurology and Neurosurgery London UK, University Clinic Freiburg Germany, Nihon University Tokyo Japan, Osaka City University Hospital, Osaka, Japan, Department of Neurosurgery at MCP Hahnemann University Pittsburgh USA, Department of Neuroendoscopy Allegheny General Hospital Pittsburg USA, Microvascular laboratory of the Department of Neurosurgery University Hospital Zurich Switzerland and the W.M. Keck Center for Collaborative Neurosciences at the State University of New Jersey Piscataway New Jersey USA.
Scientific Publications and Contributions
Dr Alok has authored 15 books and has contributed chapters to many textbooks and has over 150 scientific publications to his credit. He has made over 200 scientific presentations at International and National conferences and meetings and has organized and arranged over 25 National and International Conferences/Seminars in various specialized aspects of Neurosurgery and Regenerative Medicine.
Landmark Research Publications
World's 1st publication for Cell therapy in Autism Spectrum Disorder.
"Autologous bone marrow mononuclear cell therapy for autism - an open label proof of concept study". Alok Sharma, et al. Stem cell international. 2013 (2013), Article ID 623875, 13 pages. Click here to access full text file.
World's 1st Publication for Cell therapy in Intellectual Disability.
"An open-label proof-of-concept study of intrathecal autologous bone marrow mononuclear cell transplantation in intellectual disability". Alok Sharma, et al. Stem cell research and therapy. 2018; 9 (1):19 Click here to access full text file.
World's 1st Publication for Cell therapy in Limb Girdle Muscular Dystrophy.
"The role of cell transplantation in modifying the course of limb girdle muscular dystrophy: a longitudinal 5-year study". Alok Sharma, et al. Degenerative Neurological and Neuromuscular Disease 2015:5 93–102. Click here to access full text file.
World's 1st Publication on age-related developmental metabolic changes in the brains of children with autism.
"The Baseline Pattern and Age‐related Developmental Metabolic Changes in the Brain of Children with Autism as Measured on Positron Emission Tomography/Computed Tomography Scan". Alok Sharma, et al. World J Nucl Med 2018;17. Click here to access full text article.
Other Significant Publications
- A Clinical Study of Autologous Bone Marrow Mononuclear Cells for Cerebral Palsy Patients: A New Frontier. by Dr Alok Sharma, et al. Stem Cells International, Volume 2015, Article ID 905874, 11 pages. Click here to access full text article.
- Role of Autologous Bone Marrow Mononuclear Cells in Chronic Cervical Spinal Cord Injury-A Long Term Follow Up Study. by Dr Alok Sharma, et al. J Neurol Disord 1: 138. Click here to access full text article.
- Detailed analysis of the clinical effects of cell therapy for thoracolumbar spinal cord injury: an original study. by Dr Alok Sharma, et al. Journal of Neurorestoratology. 2013; 1:13-22. Click here to access full text article.
- Cell therapy attempted as a novel approach for chronic traumatic brain injury - a pilot study. by Dr Alok Sharma, et al. SpringerPlus (2015) 4:26. Click here to access full text article.
- Autologous Bone Marrow Mononuclear Cells Intrathecal Transplantation in Chronic Stroke. by Dr Alok Sharma, et al. Stroke Research and Treatment, Volume 2014, pages 1-9. Click here to access full text article.
- A clinical study shows safety and efficacy of autologous bone marrow mononuclear cell therapy to improve the quality of life in muscular dystrophy patients. by Dr Alok Sharma, et al. Cell Transplantation. 2013 Vol. 22, Supplement 1, pp. S127–S138. Click hereto access full text article.
- The effect of autologous bone marrow mononuclear cell transplantation on the survival duration in Amyotrophic Lateral Sclerosis - a retrospective controlled study. by Dr Alok Sharma, et al. Am J Stem Cells 2015;4(1). Click here to access full text article.
- Administration of autologous bone marrow derived mononuclear cells in children with incurable neurological disorders and injury is safe and improves their quality of life. by Dr Alok Sharma, Nandini Gokulchandran, Guneet Chopra, Pooja Kulkarni, Mamta Lohia, Prerna Badhe, V.C. Jacob. Cell Transplantation, 2012; 21 Supp 1: S1 – S12. Click here to access full text article.
- Rethinking on ethics and regulations in cell therapy as part of neurorestoratology. by Dr Alok Sharma, et al. Journal of Neurorestoratology 2016:4 1–14. Click here to access full text article.
Click here for a list of all 119 publications.
- “The Rose of Paracelsus Award” by European Medical Association (EMA's) and Socrates Nomination Committee (Oxford, UK) at Cannes, France, 2016
- "Best Hospital" by Europe business assembly (EVA) at Dubai, 2017.
- “Inspirational Company” by World Confederation of Business at St. Thomas, Virgin Islands, USA, 2017.
- "European Awards for Best Practices 2018" by European Society of Quality Research at Brussels, Belgium, 2018.
- “Sushrut Award”, Mumbai, India in 2010.
- “National Healthcare Excellence Award” New Delhi, India in 2016.
- "The Best Stem Cell Therapy Centre in India" by National Healthcare Excellence Award at New Delhi, India in 2016.
- "Emerging Stem Cell and Neurology Centre in the year (India)" at New Delhi, India in December 2016.
- "The Best Stem Cell Therapy center in Maharashtra" by Navbharat Healthcare Excellence award at the hands of Honorable Chief Minister of Maharashtra, Mr. Devendra Fadnavis at Mumbai, India, June 2017.
- "Best Super Specialty Hospital" of the year 2017, at New Delhi, India.
- "Quality Health Services in Neuro Sciences" by International Excellence Awards, at Goa, India in 2017.
- "International Excellence Award for Service to Disabilities" at the hands of Honorable Minister of Social Justice and Empowerment, Dr Thawarchand Gehlot at Delhi in 2017.
- "Excellence in Stem Cell Therapy in Maharashtra" by India today at the hands of Honorable Public Health Minister of Maharashtra, Dr Deepak Sawant at Mumbai, India in 2018.
- "Best Institute of Stem Cells and Research Center in India" at the hands of Honorable Minister of State in the Ministry of Health and Family Welfare, Government of India, Smt. Anupriya Patel at Mumbai, India in 2018
- India’s first “Dorsal Column Stimulation Operation” for Persistent Vegetative Coma, 1999.
- India’s first “Motor Cortex Stimulation operation” for intractable pain following Thalamic Intracerebral bleed, November 2006.
- Successfully performed the surgical removal of the Largest recorded collection of Intracranial Worm cysts (Hydatid) in the world.
Other Neurosurgical Special Interests
- Neurotrauma (Head injury and Spinal cord injury), Neuroendoscopy, Spinal reconstructive surgery, Cerebrovascular surgery for ischemic stroke, Neurostimulation, Stereotactic and Functional Neurosurgery, Psychosurgery.